Clinical Study on the treatment of upper gastrointestinal bleeding with self-made traditional Chinese medicine prescription(Xue′an Weikang)combined with Western medicine

doi:10.3877/cma.j.issn.2095-2015.2022.01.006

Abstract

Abstract:

Objective

To explore the combined effect of self-made traditional Chinese medicine(TCM)prescription(Xue′an Weikang)and Western medicine in the clinical treatment of upper gastrointestinal bleeding.

Methods

A total of 100 patients with upper gastrointestinal bleeding admitted to Shouguang People′s Hospital from April 2020 to September 2021 were selected and randomly divided into 2 groups with 50 cases in each group by random number table method.The control group was treated with conventional Western medicine, and the study group was treated with self-made TCM prescription(Xue′an Weikang)combined with Western medicine.The therapeutic effect, adverse reactions and related clinical indicators of the two groups were compared.

Results

The total effective rate in the study group(98.00%)was significantly higher than that in the control group(88.00%)(P<0.05). The TCM syndrome score of the study group was significantly lower than that of the control group(P<0.05). The total incidence of adverse reactions in the study group(6.00%)was significantly lower than that in the control group(16.00%)(P<0.05). The symptom improvement time of patients in the study group was significantly shorter than that in the control group, and the rebleeding rate(2.00%)was significantly lower than that in the control group(10.00%)(P<0.05).

Conclusion

The self-made TCM prescription(Xue′an Weikang)combined with Western medicine has outstanding clinical effects in the treatment of patients with upper gastrointestinal bleeding.It can not only improve the overall treatment efficiency, promote the rapid disappearance of clinical symptoms, but also significantly reduce the adverse drug reactions, and the combined effect is outstanding.

Key words: Upper gastrointestinal bleeding, Traditional Chinese medicine prescriptions, Xue′an Weikang, Therapeutic effect, Adverse reactions

Chunjuan Jia, Xiancun Fang, Yunxia Liu, Huaqing Wu. Clinical Study on the treatment of upper gastrointestinal bleeding with self-made traditional Chinese medicine prescription(Xue′an Weikang)combined with Western medicine[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2022, 12(01): 26-29.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2022.01.006

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2022/V12/I01/26

Figures/Tables 4

References 16

1	张茜，李秋荣，李菁．细节护理在奥曲肽联合奥美拉唑治疗上消化道出血中的应用及其对患者凝血指标的影响[J]．血栓与止血学，2019，25(2)：136-138.
2	Polychronis ,，Gatos-Gatopoulos ,，Georgios ，et al.Adhering to quality medical care：a case report of upper gastrointestinal bleeding due to self-expandable metal stent placed for benign duodenal obstruction[J]．Ann Transl Med，2018，6(13)：268.
3	陆艾阳子，高卉，刘宏宇，等．比较泻心汤与常用西药治疗上消化道出血的疗效[J]．中国中医急症，2018，27(10)：27-31，35.
4	林笑晗，田尧．血凝酶联合雷贝拉唑治疗上消化道出血的疗效观察[J]．现代药物与临床，2018，33(9)：2365-2368.
5	孙浩，张海涛，宁玉凤．乌司他丁联合内镜下金属钛夹止血治疗上消化道出血患者临床疗效及对血清维生素E，皮质醇水平影响[J]．临床军医杂志，2019，47(8)：74-75.
6	中华人民共和国卫生部药政局．新药(中药)治疗吐血、黑便(上消化道出血)临床研究指导原则[J]．中国医药学报，1989，4(5)：73-75.
7	葛均波，徐永健，王辰，等．内科学[M].9版．北京：人民卫生出版社，2018：451.
8	董涛，王韶华，韩永鹏．雷贝拉唑与奥美拉唑在非食管胃静脉曲张上消化道出血患者中的疗效差异[J]．河北医药，2019，41(8)：1197-1199.
9	牟大礼．胃镜下喷洒生肌止血散治疗上消化道出血的效果及对止血时间，中医症候和再出血率的影响[J]．四川中医，2019，37(8)：121-125.
10	花静，章红燕．Rockall积分干预对肝硬化急性上消化道出血患者康复治疗的影响[J]．中西医结合肝病杂志，2019，29(5)：424-426.
11	Ars A,，Ng A,，Ak A，et al.The Use of the Over the Scope Clip to Treat Upper Gastrointestinal Bleeding-ScienceDirect[J]．Gastrointest Endosc Clin N Am，2020，30(1)：1-11.
12	张飞，刘斌，施彦卿，等．肝硬化上消化道出血患者并发肝性脑病的危险因素分析[J]．中国中西医结合消化杂志，2018，26(11)：46-49.
13	陈子清，陈永华，赖世铿．内镜下套扎联合普萘洛尔对肝硬化上消化道出血患者血流动力学影响以及疗效分析[J]．中国中西医结合消化杂志，2018，26(8)：42-45.
14	鄢家苗，许霞．非静脉曲张性上消化道出血患者胃内酸性水平和CYP2C19基因多态性与奥美拉唑给药方式关系[J]．中国中西医结合消化杂志，2020，28(6)：64-69.
15	全碧泉，周琛琛．自拟复元止血散联合生长抑素治疗肝硬化合并上消化道出血的临床观察[J]．中国中医急症，2018，27(12)：141-144.
16	刘晓东，郭晓会，崔星亮，等．甘草人参止血颗粒剂和汤剂治疗肝硬化上消化道出血疗效比较[J]．现代中西医结合杂志，2018，27(6)：641-644.

组别	例数	痊愈	显效	有效	无效	总有效率
研究组	50	15(30.00)	22(44.00)	12(24.00)	1(2.00)	49(98.00)
对照组	50	12(24.00)	17(34.00)	15(30.00)	6(12.00)	44(88.00)
χ²值		0.913	2.101	0.913	7.680	7.680
P值		0.339	0.147	0.339	0.005	0.005

组别	例数	痊愈	显效	有效	无效	总有效率
研究组	50	15(30.00)	22(44.00)	12(24.00)	1(2.00)	49(98.00)
对照组	50	12(24.00)	17(34.00)	15(30.00)	6(12.00)	44(88.00)
χ²值		0.913	2.101	0.913	7.680	7.680
P值		0.339	0.147	0.339	0.005	0.005

组别	例数	黑便		呕血		头晕		总积分
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
研究组	50	2.54±0.71	0.27±0.09	0.39±0.09	0.09±0.01	1.68±0.88	0.52±0.17	4.61±1.34	0.88±0.23
对照组	50	2.56±0.58	0.48±0.11	0.41±0.11	0.15±0.07	1.71±0.89	0.88±0.21	4.68±1.35	1.51±0.52
t值		0.154	10.447	0.995	6.000	0.169	9.421	0.260	7.834
P值		0.877	0.000	0.322	0.000	0.865	0.000	0.795	0.000

组别	例数	黑便		呕血		头晕		总积分
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
研究组	50	2.54±0.71	0.27±0.09	0.39±0.09	0.09±0.01	1.68±0.88	0.52±0.17	4.61±1.34	0.88±0.23
对照组	50	2.56±0.58	0.48±0.11	0.41±0.11	0.15±0.07	1.71±0.89	0.88±0.21	4.68±1.35	1.51±0.52
t值		0.154	10.447	0.995	6.000	0.169	9.421	0.260	7.834
P值		0.877	0.000	0.322	0.000	0.865	0.000	0.795	0.000

组别	例数	嗜睡	头晕	头痛	总发生率
研究组	50	1(2.00)	1(2.00)	1(2.00)	3(6.00)
对照组	50	3(6.00)	3(6.00)	2(4.00)	8(16.00)
χ²值		2.083	2.083	0.687	5.107
P值		0.148	0.148	0.407	0.023

Please choose a citation manager

Content to export